StonvexLoading…
StonvexStonvexStonvexCore line items from FHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $478.96M | $1.80B | $1.32B | $848.38M |
Operating Income | $126.33M | $513.88M | $378.31M | $248.86M |
Net Income | $96.38M | $403.30M | $296.26M | $192.13M |
EPS (Diluted) | $1.27 | $5.13 | $3.75 | $2.40 |
Total Assets | $2.14B | $2.23B | $2.18B | $2.15B |
Total Liabilities | $880.97M | $965.86M | $931.47M | $874.49M |
Cash & Equivalents | $513.88M | $582.54M | $506.28M | $370.99M |
Free Cash Flow OCF − CapEx | $24.00M | $294.58M | $132.96M | $31.33M |
Shares Outstanding | 72.65M | 75.10M | 75.54M | 76.30M |